|
Title
|
|
|
|
Loss of furin in β-cells induces an mTORC1-ATF4 anabolic pathway that leads to β-cell dysfunction
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| FURIN is a proprotein convertase (PC) responsible for proteolytic activation of a wide array of precursor proteins within the secretory pathway. It maps to the PRC1 locus, a type 2 diabetes susceptibility locus, but its specific role in pancreatic beta-cells is largely unknown. The aim of this study was to determine the role of FURIN in glucose homeostasis. We show that FURIN is highly expressed in human islets, whereas PCs that potentially could provide redundancy are expressed at considerably lower levels. beta-cell-specific Furin knockout (beta FurKO) mice are glucose intolerant as a result of smaller islets with lower insulin content and abnormal dense-core secretory granule morphology. mRNA expression analysis and differential proteomics on beta FurKO islets revealed activation of activating transcription factor 4 (ATF4), which was mediated by mammalian target of rapamycin C1 (mTORC1). beta FurKO cells show impaired cleavage or shedding of vacuolar-type ATPase (V-ATPase) subunits Ac45 and prorenin receptor, respectively, and impaired lysosomal acidification. Blocking V-ATPase pharmacologically in beta-cells increased mTORC1 activity, suggesting involvement of the V-ATPase proton pump in the phenotype. Taken together, these results suggest a model of mTORC1-ATF4 hyperactivation and impaired lysosomal acidification in beta-cells lacking Furin, causing beta-cell dysfunction. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Diabetes / American Diabetes Association. - New York, N.Y., - 2006
| |
|
Publication
|
|
|
|
New York, N.Y.
:
2021
| |
|
ISSN
|
|
|
|
0012-1797
[print]
1939-327X
[online]
| |
|
DOI
|
|
|
|
10.2337/DB20-0474
| |
|
Volume/pages
|
|
|
|
70
:2
(2021)
, p. 492-503
| |
|
ISI
|
|
|
|
000609243500018
| |
|
Pubmed ID
|
|
|
|
33277337
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|